Live Breaking News & Updates on ஜெஃப்பெரிஸ் ஹாங் காங்

Stay updated with breaking news from ஜெஃப்பெரிஸ் ஹாங் காங். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TodayIR: Zhaoke Ophthalmology Limited (6622) Successfully listed on the Main Board of SEHK


TodayIR: Zhaoke Ophthalmology Limited (6622) Successfully listed on the Main Board of SEHK
DJ EQS-News: Zhaoke Ophthalmology Limited (6622) Successfully listed on the Main Board of SEHK EQS-News / 29/04/2021 / 12:16 UTC+8 Zhaoke Ophthalmology(6622) Successfully Listed on Main Board of SEHK
[April 29, 2021, Hong Kong] Zhaoke Ophthalmology Limited ( Zhaoke Ophthalmology or the Company ; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, was successfully listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ( SEHK ) today.
Goldman Sachs (Asia) L.L.C., and Jefferies Hong Kong Limited are the Joint Sponsors, Joint Representatives, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers. ....

Hong Kong , Li Xiaoyi , Lee Pharm , Kostenloser Wertpapierhandel , Goldman Sachs Asia , Marketing Press , Jefferies Hong Kong , Stock Exchange Of Hong Kong Limited , Zhaoke Ophthalmology , Zhaoke Ophthalmology Limited , Main Board , Successfully Listed , Ophthalmology Limited , Stock Exchange , Hong Kong Limited , Jefferies Hong Kong Limited , Joint Sponsors , Joint Representatives , Joint Global Coordinators , Joint Bookrunners , Joint Lead , Executive Director , Marketing Press Release , Dow Jones Newswires , ஹாங் காங் , லீ பார்ம் ,